Affinia Therapeutics is expanding what's possible in adeno-associated virus (AAV) gene therapy today and bringing transformative medicines for people.
People also ask
What is Affinia Therapeutics stock symbol?
How do AAV vectors work?
Jun 3, 2021 · Affinia Therapeutics is an innovative gene therapy company focused on broadening the reach of gene therapy. Our proprietary Affinia ...
Affinia Therapeutics is a rapidly growing biotech company developing transformative AAV gene therapies for devastating diseases.
Affinia Therapeutics. Biotechnology Research. Waltham, Massachusetts 8,697 followers. Building the next generation of gene therapies. See jobs Follow.
Missing: biotech | Show results with:biotech
May 3, 2021 · Affinia Therapeutics, a biotech developing adeno-associated virus vectors and gene therapies, has raked in $110 million through a series B ...
7 days ago · Affinia Therapeutics is pioneering a shift to a new class of rationally designed gene therapies that treat rare and prevalent diseases. Affinia ...
AFTX IPO News - Gene therapy biotech Affinia Therapeutics ...
www.renaissancecapital.com › IPO-Center
Dec 2, 2022 · Gene therapy biotech Affinia Therapeutics withdraws $100 million IPO ... Affinia Therapeutics, a preclinical biotech developing novel gene ...